Latest filing published 01 Jul 2021 for Strides Pharma Science Limited, €61k.
Filing timeline
BuySaleSanjay Singh: trading record in brief
Sanjay Singh (chief executive) discloses dealings in Strides Pharma Science Limited to SEBI (PIT + SAST). The record holds 3 filings, for trades running from 27 May 2021 to 30 June 2021.
The open-market record consists of 1 sale worth €47k, with no purchase. Outside the open market, there are 2 share grants.
The newest entry dates from 1 July 2021: a share grant of €61k, in Strides Pharma Science Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sanjay Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ ₹269.700.0001% mcap49.8% of flowEquity SharesSEBI:8a4f4b71affa6d0c9a21cfeb56e0d360739d7fa8Canonical exit: 28 Sept 2021 (T+90)
- 5,000 shares@ ₹826.000.0001% mcap37.9% of flowEquity SharesSEBI:9d47d19f75b03ab068ee36b023d2f08ffc9ee386
- 5,000 shares@ ₹269.700.0000% mcap12.4% of flowEquity SharesSEBI:c310c21a01e1b9cbf1eabadf954ba4a08c1a6e47Canonical exit: 25 Aug 2021 (T+90)
3 of 3 declarations